Supporting parents of children with incurable cancer

Increased stroke risk in childhood cancer survivors

Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia

Bispecific CD19/22 CAR therapy in children and young adults with ALL

Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia

Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL

ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas

Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients

The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients

Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy

Latest analysis of the ELIANA trial for acute lymphocytic leukaemia